BioNTech SE (BNTX)
Biological Products, (No Diagnostic Substances)
Latest Price
$90.58
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
18.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5.86M | $520.0M | 2.33% | +2.77M | 2026-03-31 |
| FMR LLC | 5.71M | $507.0M | 2.27% | -224.4K | 2026-03-31 |
| PRIMECAP MANAGEMENT CO/CA/ | 3.79M | $337.0M | 1.51% | -6.3K | 2026-03-31 |
| FLOSSBACH VON STORCH SE | 3.68M | $327.0M | 1.46% | -515.7K | 2026-03-31 |
| Dodge & Cox | 3.68M | $326.0M | 1.46% | +62.3K | 2026-03-31 |
| BlackRock, Inc. | 1.66M | $147.0M | 0.66% | +505.3K | 2026-03-31 |
| BNP PARIBAS FINANCIAL MARKETS | 1.65M | $148.0M | 0.66% | +73.9K | 2026-03-31 |
| CITADEL ADVISORS LLC | 1.54M | $136.0M | 0.61% | +518.1K | 2026-03-31 |
| Temasek Holdings (Private) Ltd | 1.51M | $133.0M | 0.60% | -- | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 903.0K | $80.0M | 0.36% | +166.4K | 2026-03-31 |